Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P900066/S017

ISPAN Perfluoropropane C3F8 Gas

Airgas Therapeutics, LLC · Decision date Apr 30, 2026

FDA DECISIONP900066/S017

What did the FDA decide?

FDA records P900066/S017 as a supplement to PMA P900066, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Apr 30, 2026.

FDA approval order statement

Approval to institute Agilent 8890 gas chromatograph and Metrohm 930 ion chromatograph as redundant instruments for the final product release testing.
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Ophthalmic
Decision date
Apr 30, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P900066/S017
Regulatory pathway
PMA supplement
Product code
LPO
Decision code
OK30
Decision date
Apr 30, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Gases used within eye to place pressure on detached retina.

Product code
LPO
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P900066/S017 received

    Application receipt date recorded by FDA.

  2. P900066/S017 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P900066. View FDA’s full supplement list.

Related devices and submissions

Explore the linked device profile

Other records with product code LPO

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Airgas Therapeutics, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
6141 Easton Rd., Plumsteadville, PA, 18949

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records